Belite Bio, Inc SEC filings BLTE
Belite Bio, Inc has 214 filings in SEC EDGAR's recent list, going back to Dec 1, 2021. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 19, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 30, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 30, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 144 | Notice of proposed sale | Jun 18, 2026 | — |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 144 | Notice of proposed sale | Jun 16, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 4 | Insider transaction | May 8, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | Apr 30, 2026 | Apr 29, 2026 |
| 4 | Insider transaction | Apr 29, 2026 | Apr 28, 2026 |
| 4 | Insider transaction | Apr 28, 2026 | Apr 27, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 24, 2026 |
| 4 | Insider transaction | Apr 24, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 21, 2026 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 21, 2026 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 22, 2026 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 21, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 21, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 20, 2026 | Apr 17, 2026 |
| 4 | Insider transaction | Apr 20, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 15, 2026 |
| 144 | Notice of proposed sale | Apr 15, 2026 | — |
| 4 | Insider transaction | Apr 13, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 13, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 13, 2026 | Apr 9, 2026 |
| 144 | Notice of proposed sale | Apr 9, 2026 | — |
| 144 | Notice of proposed sale | Apr 9, 2026 | — |
| 144 | Notice of proposed sale | Apr 9, 2026 | — |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 10, 2025 | — |
| 144 | Notice of proposed sale | Oct 17, 2025 | — |
| 144 | Notice of proposed sale | Oct 16, 2025 | — |
| 144 | Notice of proposed sale | Oct 14, 2025 | — |
| 144 | Notice of proposed sale | Oct 14, 2025 | — |
| 144 | Notice of proposed sale | Sep 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 21, 2025 | — |
| 144 | Notice of proposed sale | May 21, 2025 | — |
| 144 | Notice of proposed sale | Mar 19, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2025 | — |
| 144 | Notice of proposed sale | Jan 2, 2025 | — |
| 144 | Notice of proposed sale | Jan 2, 2025 | — |
| 144 | Notice of proposed sale | Nov 20, 2024 | — |
| 144 | Notice of proposed sale | Nov 19, 2024 | — |
| 144/A | Filing | Oct 8, 2024 | — |
| 144/A | Filing | Oct 8, 2024 | — |
| 144 | Notice of proposed sale | Oct 3, 2024 | — |
| 144 | Notice of proposed sale | Oct 3, 2024 | — |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 144 | Notice of proposed sale | Sep 4, 2024 | — |
| 144 | Notice of proposed sale | Aug 16, 2024 | — |
| 144 | Notice of proposed sale | Aug 14, 2024 | — |
| 144 | Notice of proposed sale | Aug 14, 2024 | — |
| 144 | Notice of proposed sale | Aug 14, 2024 | — |
| 144 | Notice of proposed sale | Jun 4, 2024 | — |
| 144 | Notice of proposed sale | May 30, 2024 | — |
| 144 | Notice of proposed sale | May 30, 2024 | — |
| 144 | Notice of proposed sale | May 17, 2024 | — |
| 144 | Notice of proposed sale | May 16, 2024 | — |
| 144 | Notice of proposed sale | Mar 22, 2024 | — |
| 144 | Notice of proposed sale | Mar 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2024 | — |
| 144 | Notice of proposed sale | Dec 28, 2023 | — |
| 144 | Notice of proposed sale | Dec 28, 2023 | — |
| 144 | Notice of proposed sale | Nov 28, 2023 | — |
| 144 | Notice of proposed sale | Nov 16, 2023 | — |
| 144 | Notice of proposed sale | Nov 16, 2023 | — |
| 144 | Notice of proposed sale | Aug 31, 2023 | — |
| 144 | Notice of proposed sale | Aug 31, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 15, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
Showing 100 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BLTE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1889109
- Former names
- BELITE BIO, INC (until Oct 30, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.